Jennifer Fitzpatrick
Fortuna: 339 278 $ al 31/08/2026
Fortuna: 339 278 $ al 31/08/2026
Jennifer Fitzpatrick is Chief Legal Officer at Sionna Therapeutics, Inc. starting in 2025.
Former positions include Secretary & Director at Aegerion Pharmaceuticals, Inc., Vice President & Corporate Counsel at SAGE Therapeutics, Inc., Corporate Counsel at Revvity, Inc., and Corporate Counsel at AVEO Pharmaceuticals, Inc. Education includes undergraduate studies at Middlebury College and graduate studies at the University of Virginia School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/09/2026 | 56.265 ( 0,12 % ) | 339 278 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SIONNA THERAPEUTICS, INC. | Consejero General | 03/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| REVVITY, INC. | Consejero General | - |
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| AVEO PHARMACEUTICALS, INC. | Consejero General | - |
| AEGERION PHARMACEUTICALS, INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
University of Virginia School of Law
University of Virginia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.